Physiomics (LON:PYC) Shares Up 38.6% – Still a Buy?

Physiomics Plc (LON:PYC)’s stock price was up 38.6% during trading on Friday . The company traded as high as GBX 0.70 and last traded at GBX 0.69. Approximately 12,270,827 shares were traded during trading, an increase of 53% from the average daily volume of 8,006,103 shares. The stock had previously closed at GBX 0.50.

Physiomics Trading Up 38.6%

The company has a 50-day moving average of GBX 0.33 and a 200-day moving average of GBX 0.39. The firm has a market capitalization of £2.10 million, a price-to-earnings ratio of -4.08 and a beta of 1.69.

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.